Effect of Calcipotriol Plus Hydrocortisone Ointment on the HPA Axis and Calcium Metabolism in Patients With Psoriasis Vulgaris on the Face and on the Intertriginous Areas.

Trial Profile

Effect of Calcipotriol Plus Hydrocortisone Ointment on the HPA Axis and Calcium Metabolism in Patients With Psoriasis Vulgaris on the Face and on the Intertriginous Areas.

Completed
Phase of Trial: Phase II

Latest Information Update: 30 Oct 2013

At a glance

  • Drugs Calcipotriol/hydrocortisone (Primary)
  • Indications Plaque psoriasis
  • Focus Pharmacodynamics
  • Most Recent Events

    • 24 Mar 2012 Additional trial location (United Kingdom) added as reported by European Clinical Trials Database.
    • 24 Mar 2012 Planned number of patients changed from 30 to 35 as reported by European Clinical Trials Database.
    • 18 Dec 2009 Actual number of patients (33) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top